Vaccine protection against acquisition of neutralization-resistant SIV challenges in rhesus monkeys

被引：394

作者：

Barouch, Dan H. ^{[1
,2
]}

Liu, Jinyan ^{[1
]}

Li, Hualin ^{[1
]}

Maxfield, Lori F. ^{[1
]}

Abbink, Peter ^{[1
]}

Lynch, Diana M. ^{[1
]}

Iampietro, M. Justin ^{[1
]}

SanMiguel, Adam ^{[1
]}

Seaman, Michael S. ^{[1
]}

Ferrari, Guido ^{[3
]}

Forthal, Donald N. ^{[4
]}

Ourmanov, Ilnour ^{[5
]}

Hirsch, Vanessa M. ^{[5
]}

Carville, Angela ^{[6
]}

Mansfield, Keith G. ^{[6
]}

Stablein, Donald ^{[7
]}

Pau, Maria G. ^{[8
]}

Schuitemaker, Hanneke ^{[8
]}

Sadoff, Jerald C. ^{[8
]}

Billings, Erik A. ^{[9
]}

Rao, Mangala ^{[9
]}

Robb, Merlin L. ^{[9
]}

Kim, Jerome H. ^{[9
]}

Marovich, Mary A. ^{[9
]}

Goudsmit, Jaap ^{[8
]}

Michael, Nelson L. ^{[9
]}

机构：

[1] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Div Vaccine Res, Boston, MA 02215 USA

[2] Ragon Inst MGH MIT & Harvard, Boston, MA 02114 USA

[3] Duke Univ, Med Ctr, Durham, NC 27710 USA

[4] Univ Calif Irvine, Sch Med, Irvine, CA 92717 USA

[5] NIAID, Bethesda, MA 20892 USA

[6] New England Primate Res Ctr, Southborough, MA 01772 USA

[7] EMMES Corp, Rockville, MD 20850 USA

[8] Crucell Holland BV, NL-2301 CA Leiden, Netherlands

[9] Walter Reed Army Inst Res, US Mil HIV Res Program, Silver Spring, MD 20910 USA

来源：

NATURE | 2012年 / 482卷 / 7383期

基金：

美国国家卫生研究院;

关键词：

CELLULAR IMMUNE-RESPONSES; LOW-DOSE CHALLENGE; INFECTION; ANTIBODIES; MACAQUES; VECTORS; MEMORY; BREADTH;

D O I：

10.1038/nature10766

中图分类号：

O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];

学科分类号：

07 ; 0710 ; 09 ;

摘要：

Preclinical studies of human immunodeficiency virus type 1 (HIV-1) vaccine candidates have typically shown post-infection virological control, but protection against acquisition of infection has previously only been reported against neutralization-sensitive virus challenges(1-3). Here we demonstrate vaccine protection against acquisition of fully heterologous, neutralization-resistant simian immunodeficiency virus (SIV) challenges in rhesus monkeys. Adenovirus/poxvirus and adenovirus/adenovirus-vector-based vaccines expressing SIVSME543 Gag, Pol and Env antigens resulted in an 80% or greater reduction in the per-exposure probability of infection(4,5) against repetitive, intrarectal SIVMAC251 challenges in rhesus monkeys. Protection against acquisition of infection showed distinct immunological correlates compared with post-infection virological control and required the inclusion of Env in the vaccine regimen. These data demonstrate the proof-of-concept that optimized HIV-1 vaccine candidates can block acquisition of stringent, heterologous, neutralization-resistant virus challenges in rhesus monkeys.

引用

页码：89 / U115

页数：6

共 30 条

[1] Comparative seroprevalence and immunogenicity of six rare serotype recombinant adenovirus vaccine vectors from subgroups B and D
Abbink, Peter
Lemckert, Angelique A. C.
Ewald, Bonnie A.
Lynch, Diana M.
Denholtz, Matthew
Smits, Shirley
Holterman, Lennart
Damen, Irma
Vogels, Ronald
Thorner, Anna R.
O'Brien, Kara L.
Carville, Angela
Mansfield, Keith G.
Goudsmit, Jaap
Havenga, Menzo J. E.
Barouch, Dan H.
[J]. JOURNAL OF VIROLOGY, 2007, 81 (09) : 4654 - 4663
[2] Antibody-Mediated Protection against Mucosal Simian-Human Immunodeficiency Virus Challenge of Macaques Immunized with Alphavirus Replicon Particles and Boosted with Trimeric Envelope Glycoprotein in MF59 Adjuvant
Barnett, Susan W.
Burke, Brian
Sun, Yide
Kan, Elaine
Legg, Harold
Lian, Ying
Bost, Kristen
Zhou, Fengmin
Goodsell, Amanda
zur Megede, Jan
Polo, John
Donnelly, John
Ulmer, Jeffrey
Otten, Gillis R.
Miller, Christopher J.
Vajdy, Michael
Srivastava, Indresh K.
[J]. JOURNAL OF VIROLOGY, 2010, 84 (12) : 5975 - 5985
[3] Mosaic HIV-1 vaccines expand the breadth and depth of cellular immune responses in rhesus monkeys
Barouch, Dan H.
O'Brien, Kara L.
Simmons, Nathaniel L.
King, Sharon L.
Abbink, Peter
Maxfield, Lori F.
Sun, Ying-Hua
La Porte, Annalena
Riggs, Ambryice M.
Lynch, Diana M.
Clark, Sarah L.
Backus, Katherine
Perry, James R.
Seaman, Michael S.
Carville, Angela
Mansfield, Keith G.
Szinger, James J.
Fischer, Will
Muldoon, Mark
Korber, Bette
[J]. NATURE MEDICINE, 2010, 16 (03) : 319 - U116
[4] An HIV-1 gp120 Envelope Human Monoclonal Antibody That Recognizes a C1 Conformational Epitope Mediates Potent Antibody-Dependent Cellular Cytotoxicity (ADCC) Activity and Defines a Common ADCC Epitope in Human HIV-1 Serum
Ferrari, Guido
Pollara, Justin
Kozink, Daniel
Harms, Tiara
Drinker, Mark
Freel, Stephanie
Moody, M. Anthony
Alam, S. Munir
Tomaras, Georgia D.
Ochsenbauer, Christina
Kappes, John C.
Shaw, George M.
Hoxie, James A.
Robinson, James E.
Haynes, Barton F.
[J]. JOURNAL OF VIROLOGY, 2011, 85 (14) : 7029 - 7036
[5] Antibody from patients with acute human immunodeficiency virus (HIV) infection inhibits primary strains of HIV type 1 the presence of natural-killer effector cells
Forthal, DN
Landucci, G
Daar, ES
[J]. JOURNAL OF VIROLOGY, 2001, 75 (15) : 6953 - 6961
[6] Targeting early infection to prevent HIV-1 mucosal transmission
Haase, Ashley T.
[J]. NATURE, 2010, 464 (7286) : 217 - 223
[7] Profound early control of highly pathogenic SIV by an effector memory T-cell vaccine
Hansen, Scott G.
Ford, Julia C.
Lewis, Matthew S.
Ventura, Abigail B.
Hughes, Colette M.
Coyne-Johnson, Lia
Whizin, Nathan
Oswald, Kelli
Shoemaker, Rebecca
Swanson, Tonya
Legasse, Alfred W.
Chiuchiolo, Maria J.
Parks, Christopher L.
Axthelm, Michael K.
Nelson, Jay A.
Jarvis, Michael A.
Piatak, Michael, Jr.
Lifson, Jeffrey D.
Picker, Louis J.
[J]. NATURE, 2011, 473 (7348) : 523 - U270
[8] Haynes B, 2011, AIDS VACC C 2011
[9] Assessing Vaccine Effects in Repeated Low-Dose Challenge Experiments
Hudgens, Michael G.
Gilbert, Peter B.
[J]. BIOMETRICS, 2009, 65 (04) : 1223 - 1232
[10] Power to Detect the Effects of HIV Vaccination in Repeated Low-Dose Challenge Experiments
Hudgens, Michael G.
Gilbert, Peter B.
Mascola, John R.
Wu, Chih-Da
Barouch, Dan H.
Self, Steven G.
[J]. JOURNAL OF INFECTIOUS DISEASES, 2009, 200 (04) : 609 - 613

← 1 2 3 →